Skip to content
Disclosery

EXANE DERIVATIVES: IBM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on IBM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 16,200 IBM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 16,200 shares
    Change vs previous 13F -5,413 shares

    1.31% of the 13F portfolio, value $2,287,056.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 21,613 shares
    Change vs previous 13F -2,189 shares

    0.79% of the 13F portfolio, value $2,810,142.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 23,802 shares
    Change vs previous 13F +15,425 shares

    0.77% of the 13F portfolio, value $3,181,478.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 8,377 shares
    Change vs previous 13F -1,827 shares

    0.29% of the 13F portfolio, value $1,163,863.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 10,204 shares
    Change vs previous 13F -692 shares

    0.34% of the 13F portfolio, value $1,431,449.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 10,896 shares
    Change vs previous 13F -1,015 shares

    0.44% of the 13F portfolio, value $1,452,068.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 11,911 shares
    Change vs previous 13F -2,016 shares

    0.45% of the 13F portfolio, value $1,499,423.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 13,927 shares
    Change vs previous 13F not available

    0.55% of the 13F portfolio, value $1,694,544.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).